“…Recently, two studies have identified significantly more cytotoxic lymphocytes (CD3, CD8 and TIA-1) and a higher rate of cells undergoing apoptosis in MSI-H colorectal carcinomas than in MSI-L and MSS (Dolcetti et al, 1999;Michael-Robinson et al, 2001). Furthermore, patients with MSI-H tumours and a high content of activated cytotoxic lymphocytes showed improved overall survival (Guidoboni et al, 2001). Some studies have reported improved survival among colorectal cancer patients with microsatellite unstable tumours (Lothe et al, 1993;Thibodeau et al, 1993;Bubb et al, 1996;Lukish et al, 1998;Halling et al, 1999;Johannsdottir et al, 1999;Massa et al, 1999;Elsaleh et al, 2000;Gryfe et al, 2000;Hemminki et al, 2000;Wright et al, 2000;Ward et al, 2001;Watanabe et al, 2001), while others have not (Messerini et al, 1997;Senba et al, 1998;Feeley et al, 1999;Salahshor et al, 1999;Curran et al, 2000).…”